bpc 157 human trials reddit Peptide BPC-157 What Is BPC-157? A Medical
Description
AOD-9604 has GRAS status but no drug approval and no proven weight loss efficacy
Key finding: AOD 9604 showed superior lipolytic activity (EC50 45 nM) versus native GH (EC50 380 nM) with insulin-independent mechanism
What is the tolerability profile of AOD-9604
Effect of Cagrilintide On average, people who took cagrilintide lost nearly 12% of their body weight over 68 weeks
Many people use BPC 157 to manage chronic pain, improve flexibility, and support overall musculoskeletal health
